» Articles » PMID: 35758268

GPX4: Old Lessons, New Features

Overview
Specialty Biochemistry
Date 2022 Jun 27
PMID 35758268
Authors
Affiliations
Soon will be listed here.
Abstract

GPX4 is a selenocysteine-containing protein that plays an essential role in repairing peroxidised phospholipids. Its role in organismal homeostasis has been known for decades, and it has been reported to play a pivotal role in cell survival and mammalian embryonic development. In recent years, GPX4 has been associated with a cell death modality dubbed ferroptosis. The framing of this molecular pathway of cell death was essential for understanding the conditions that determine GPX4 dependency and ultimately to the process of lipid peroxidation. Since its discovery, ferroptosis has been gaining momentum as a promising target for yet-incurable diseases, including cancer and neurodegeneration. Given the current interest, in the present review, we provide newcomers in the field with an overview of the biology of GPX4 and cover some of its most recent discoveries.

Citing Articles

Ferroptosis, pathogenesis and therapy in AS co-depression disease.

Zhao Y, Ren P, Luo Q, Li X, Cheng X, Wen Y Front Pharmacol. 2025; 16:1516601.

PMID: 40066336 PMC: 11891183. DOI: 10.3389/fphar.2025.1516601.


JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases.

Dai Y, Cui C, Jiao D, Zhu X Cancer Cell Int. 2025; 25(1):83.

PMID: 40055704 PMC: 11889932. DOI: 10.1186/s12935-025-03681-6.


Thonningianin A ameliorates acetaminophen-induced liver injury by activating GPX4 and modulating endoplasmic reticulum stress.

Lai S, Ye Y, Ding Q, Hu X, Fu A, Wu L Front Pharmacol. 2025; 16:1531277.

PMID: 40051561 PMC: 11882853. DOI: 10.3389/fphar.2025.1531277.


[Research progress on N6-methyladenosine and ferroptosis in childhood combined allergic rhinitis and asthma syndrome].

Li J, Li Y, Lai S, Kan X Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(2):242-247.

PMID: 39962790 PMC: 11838029. DOI: 10.7499/j.issn.1008-8830.2407062.


Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.

Scarpellini C, Klejborowska G, Lanthier C, Toye A, Musialek K, Van San E J Med Chem. 2025; 68(4):4908-4928.

PMID: 39913870 PMC: 11874020. DOI: 10.1021/acs.jmedchem.4c03149.